Search
Tahoe Therapeutics has successfully concluded a $30 million funding round, led by Amplify Partners, with additional support from the venture capital division of Databricks and six other notable institutional investors. The company is dedicated to harnessing AI technology to create advanced models for simulating cancer cell behavior. Tahoe's cornerstone platform, Mosaic, boasts a comprehensive database comprising over 100 million data points related to cellular behavior. This extensive dataset will be leveraged to train AI models, enabling them to accurately simulate the intricate dynamics of living cells. This capability is poised to forecast drug responses in humans, offering robust foundational support for the development of novel therapeutics.
-
C114 Communication Network -
Communication Home
